Efficacy and Safety of Ibrutinib (IBR) after Venetoclax (VEN) Treatment in IBR-Naïve Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Follow-up of Patients from the MURANO Study
暂无分享,去创建一个
R. Greil | B. Leber | P. Marlton | G. Fraser | M. Breuleux | R. Marks | G. Semenzato | J. Middeke | K. Humphrey | W. Schary | M. Boyer | G. Quaresmini | N. Crompton